These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 25203978)
1. The drug quality and security act: how will it change pharmacy? Soukup BJ Consult Pharm; 2014; 29(5):352. PubMed ID: 25203978 [No Abstract] [Full Text] [Related]
3. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives. Blankenship C Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383 [No Abstract] [Full Text] [Related]
4. Regulating compounding pharmacies after NECC. Outterson K N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357 [No Abstract] [Full Text] [Related]
5. FDA inspections find unsafe practices in compounding pharmacies. McCarthy M BMJ; 2013 Apr; 346():f2414. PubMed ID: 23592476 [No Abstract] [Full Text] [Related]
6. Regulators faulted for inadequate compounding pharmacy oversight. Traynor K Am J Health Syst Pharm; 2013 Jan; 70(1):8-10. PubMed ID: 23261891 [No Abstract] [Full Text] [Related]
7. Drug compounding, drug safety, and the first amendment. Dresser R Hastings Cent Rep; 2013; 43(2):9-10. PubMed ID: 23494695 [No Abstract] [Full Text] [Related]
8. Improving and enforcing compounding pharmacy practices to protect patients. Pegues DA Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363 [No Abstract] [Full Text] [Related]
9. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak. Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265 [TBL] [Abstract][Full Text] [Related]
10. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists. Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883 [No Abstract] [Full Text] [Related]
11. The "Lists": What Do They Mean? Voliva J Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386 [No Abstract] [Full Text] [Related]
12. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List). Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383 [No Abstract] [Full Text] [Related]
13. Compounding pharmacies: who is in charge? Pergolizzi JV; Labhsetwar S; LeQuang JA Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709 [TBL] [Abstract][Full Text] [Related]
15. Compounding pharmacies: before and after an inspection. Kulkarni D; Ricketts S Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779 [TBL] [Abstract][Full Text] [Related]
16. 2013 State Compounding Legislation Tracker. Miller DG Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782 [No Abstract] [Full Text] [Related]
18. NABP to inspect compounding pharmacies. Traynor K Am J Health Syst Pharm; 2013 Jan; 70(2):88-90. PubMed ID: 23292258 [No Abstract] [Full Text] [Related]
19. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe. Minghetti P; Pantano D; Gennari CG; Casiraghi A Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297 [TBL] [Abstract][Full Text] [Related]